Zobrazeno 1 - 10
of 17
pro vyhledávání: '"59"'
Autor:
R. Roux, C. Butcher, G. Bertelli, Rosemary Lord, R.M. Glasspool, Shibani Nicum, Adrian Cook, Michelle Ferguson, Melanie Mackean, M. Martinez, S. Love, L. Howells, Christina Fotopoulou, Eleni Frangou, Sarah P. Blagden, Nicholas J. Hulbert-Williams
Publikováno v:
Gynecologic Oncology. 162:431-439
Background Fear of disease progression (FOP) is a rational concern for women with Ovarian Cancer (OC) and depression is also common. To date there have been no randomized trials assessing the impact of psychological intervention on depression and FOP
Abstract PS9-29: Factors influencing fatigue in breast cancer patients undergoing breast irradiation
Autor:
Bruce T. Liang, Edward Belk Perry, Rong Wu, Susan Tannenbaum, Sudhanshu B. Mulay, Xiaoyan Wang, Matthew Greenwood, Robert Dowsett, Jacob Neuwirth, Jayesh Kamath, James J. Grady
Publikováno v:
Cancer Research. 81:PS9-29
Background: Fatigue is one of the most common acute complications of radiation therapy (RT). It can have a serious impact on a patient’s quality of life and ability to engage in treatment, and has been associated with lower recurrence-free and over
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 2, Pp 1-8 (2021)
Blood Cancer Journal
Blood Cancer Journal
We conducted a prospective cohort study in newly diagnosed systemic light chain (AL) amyloidosis patients (N = 59) to study patient-reported outcomes (PROs) through the first year. The median age was 68 years with 42% female, 8% Black, and 78% lambda
Autor:
Silvia M. A. A. Evers, Martijn J.L. Bours, Frederike E C M Mulder, Matty P. Weijenberg, Eline H. van Roekel
Publikováno v:
Journal of Cancer Survivorship-Research and Practice, 16(5), 1055-1064. Springer, Cham
Purpose The aim of this study is to assess the societal burden of colorectal cancer (CRC) survivorship 2–10 years post-diagnosis in terms of (1) societal costs, and (2) quality of life/utilities, and to analyze associated patient characteristics. M
Publikováno v:
Psycho-oncologyREFERENCES. 29(8)
Objective Prior to hematopoietic stem cell transplantation (HSCT), and despite the high objective risks associated with HSCT, fear of progression (FoP) has only sparsely been studied in patients with acute leukemia until now. The aim of this study wa
Autor:
Philip Beale, Ian F. Tannock, Sean B. Rourke, Haibo Zhang, Janette L. Vardy, Gregory R. Pond, Haryana M. Dhillon, Tsegaye Bekele, Anna Dodd, Stephen Clarke, Corrinne Renton
Publikováno v:
Journal of Clinical Oncology. 33:4085-4092
Purpose Cognitive dysfunction is reported in people with cancer. Therefore, we evaluated longitudinal changes in cognitive function and underlying mechanisms in people with colorectal cancer (CRC) and healthy controls (HCs). Patients and Methods Part
Autor:
Diane C. Bodurka, Robin A. Lacour, Michael Frumovitz, Charlotte C. Sun, Diana L. Urbauer, Celestine S. Tung, Karen H. Lu, Shannon N. Westin, Larissa A. Meyer
Publikováno v:
Journal of Cancer Survivorship. 10:261-270
While overall survival from gynecologic malignancies has greatly improved over the last three decades, required treatments can lead to multiple health issues for survivors. Our objective was to identify health concerns that gynecologic cancer survivo
Autor:
Faith E. Davies, Cathy D. Williams, Jack Ishak, Irina Proskorovsky, Philip Lewis, K Payne, Noreen Lordan, Karin Jordan, Sarah Peters, Charalampia Kyriakou
Publikováno v:
Supportive Care in Cancer
Purpose Novel multiple myeloma (MM) therapies have increased patient longevity but are often associated with notable symptom burden. This study quantified the effect of general symptom level, specific symptoms, and treatment-related adverse events (A
Publikováno v:
Journal of Geriatric Oncology. 4:166-173
Objectives The purpose of this study was to gather preliminary data on both direct and moderating effects of health status, the social environment, and perceived personal control on the symptom distress and quality of life (QOL) for older patients wi
Autor:
Henry S. Friedman, Charlene Flahiff, Patrick Healy, Susan Boulton, Janet Minchew, Tulika Ranjan, Frances McSherry, James E. Herndon, Lee W. Jones, Gordana Vlahovic, Maria Freeman, Katherine B. Peters, Mary Lou Affronti, Elizabeth Miller, Sarah Woodring, Annick Desjardins, Eric S. Lipp, Dina Randazzo
After diagnosis, glioblastoma (GBM) patients quickly experience the neurological, physical, and emotional impact of their disease. Even before chemoradiation treatment, health-related quality of life (HRQoL) can be impaired and fatigue can be present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49080683598be1525bc1fcbe4cbbe29f
https://europepmc.org/articles/PMC4218503/
https://europepmc.org/articles/PMC4218503/